Michael D. Pak

Array ( [id] => 6412237 [patent_doc_number] => 20100166734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ORAL DELIVERY OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/520272 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 48093 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166734.pdf [firstpage_image] =>[orig_patent_app_number] => 12520272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 749307 [patent_doc_number] => 07022489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Method of using cells expressing galanin receptor 3 (GALR3)' [patent_app_type] => utility [patent_app_number] => 10/007132 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 43358 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022489.pdf [firstpage_image] =>[orig_patent_app_number] => 10007132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683232 [patent_doc_number] => 20030119096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Method of treating an abnormality using a GALR3 receptor antagonist' [patent_app_type] => new [patent_app_number] => 10/006343 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 43776 [patent_no_of_claims] => 239 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119096.pdf [firstpage_image] =>[orig_patent_app_number] => 10006343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571268 [patent_doc_number] => 20020165381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Human androgen receptor variants' [patent_app_type] => new [patent_app_number] => 09/997267 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6007 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165381.pdf [firstpage_image] =>[orig_patent_app_number] => 09997267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 541175 [patent_doc_number] => 07166438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'In Vitro screening for ligands of the estrogen receptor' [patent_app_type] => utility [patent_app_number] => 09/989952 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5703 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166438.pdf [firstpage_image] =>[orig_patent_app_number] => 09989952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806568 [patent_doc_number] => 07419800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Estrogen receptor genes' [patent_app_type] => utility [patent_app_number] => 10/451768 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18425 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419800.pdf [firstpage_image] =>[orig_patent_app_number] => 10451768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602315 [patent_doc_number] => 07432078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Estrogen receptor genes and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/450484 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18036 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432078.pdf [firstpage_image] =>[orig_patent_app_number] => 10450484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674320 [patent_doc_number] => 20030059923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Polynucleotide encoding a novel human potassium channel alpha-subunit, K+alphaM1, and variants thereof' [patent_app_type] => new [patent_app_number] => 09/999220 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 134966 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059923.pdf [firstpage_image] =>[orig_patent_app_number] => 09999220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406344 [patent_doc_number] => 20040024181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Novel human proteins, polynucleotides encoding them and methods of using the same' [patent_app_type] => new [patent_app_number] => 10/055569 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82198 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024181.pdf [firstpage_image] =>[orig_patent_app_number] => 10055569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432365 [patent_doc_number] => 07897357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Assay for detecting immune responses involving antigen specific cytokine and/or antigen specific cytokine secreting T-cells' [patent_app_type] => utility [patent_app_number] => 09/978669 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10362 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897357.pdf [firstpage_image] =>[orig_patent_app_number] => 09978669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548597 [patent_doc_number] => 20020137908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Novel guanosine triphosphate (GTP) binding protein-coupled receptor protein, BG3' [patent_app_type] => new [patent_app_number] => 09/963766 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9087 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137908.pdf [firstpage_image] =>[orig_patent_app_number] => 09963766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617567 [patent_doc_number] => 20020085992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Method for treating inflammation' [patent_app_type] => new [patent_app_number] => 09/951268 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12181 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20020085992.pdf [firstpage_image] =>[orig_patent_app_number] => 09951268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275955 [patent_doc_number] => 20020106671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Identification of a capacitative calcium channel in antigen presenting cells and uses thereof' [patent_app_type] => new [patent_app_number] => 09/946175 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15697 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106671.pdf [firstpage_image] =>[orig_patent_app_number] => 09946175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157717 [patent_doc_number] => 20020146765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Acetylcholine receptor subunits' [patent_app_type] => new [patent_app_number] => 09/941179 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8944 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146765.pdf [firstpage_image] =>[orig_patent_app_number] => 09941179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6176121 [patent_doc_number] => 20020155531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Small and intermediate conductance, calcium-activated potassium channels and uses thereof' [patent_app_type] => new [patent_app_number] => 09/922364 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33189 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155531.pdf [firstpage_image] =>[orig_patent_app_number] => 09922364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728153 [patent_doc_number] => 07041494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'DNA encoding Slo2 and Slo4, potassium channel' [patent_app_type] => utility [patent_app_number] => 09/921159 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 30356 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041494.pdf [firstpage_image] =>[orig_patent_app_number] => 09921159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080585 [patent_doc_number] => 20020081658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => '18610, a novel human transient receptor and uses thereof' [patent_app_type] => new [patent_app_number] => 09/920346 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40840 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081658.pdf [firstpage_image] =>[orig_patent_app_number] => 09920346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783043 [patent_doc_number] => 20030064490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Novel human ion channel proteins and polynucleotides encoding the same' [patent_app_type] => new [patent_app_number] => 09/918359 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9135 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064490.pdf [firstpage_image] =>[orig_patent_app_number] => 09918359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405335 [patent_doc_number] => 20020037556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Heliothis virescens ultraspiracle (USP) protein' [patent_app_type] => new [patent_app_number] => 09/909672 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3261 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037556.pdf [firstpage_image] =>[orig_patent_app_number] => 09909672 [rel_patent_id] =>[rel_patent_doc_number] =>)